VCYT
Veracyte
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: VCYT
- PE Ratio
As of Jun 12, 2026, the VCYT stock has a P/E ratio of 42.64. The calculation is based on the latest EPS of $1.11 and the stock price of $47.33 per share. A decrease of 30% has been observed in the PE ratio compared to its average of 61.1 of the past four quarters.
VCYT PE ratio history
The mean historical PE ratio of Veracyte over the last two years is 72.85. The current 42.64 price-to-earnings ratio is 41% less than the historical average. Analyzing the last two years, VCYT's PE ratio reached its highest point in the Dec 2024 quarter at 123.75, with a price of $39.6 and an EPS of $0.32. The Mar 2026 quarter saw the lowest point at 29.02, with a price of $32.21 and an EPS of $1.11.
Veracyte PE ratio by year
Maximum annual decrease: -59.5% in 2025
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 50.12 | -59.5% | $42.1 | $0.84 |
| 2024 | 123.75 | N/A | $39.6 | $0.32 |
| 2023 | N/A | N/A | $27.51 | -$1.02 |
| 2022 | N/A | N/A | $23.73 | -$0.51 |
| 2021 | N/A | N/A | $41.2 | -$1.11 |
| 2020 | N/A | N/A | $48.94 | -$0.66 |
| 2019 | N/A | N/A | $27.92 | -$0.27 |
| 2018 | N/A | N/A | $12.58 | -$0.62 |
| 2017 | N/A | N/A | $6.53 | -$0.91 |
| 2016 | N/A | N/A | $7.74 | -$1.09 |
| 2015 | N/A | N/A | $7.2 | -$1.3 |
| 2014 | N/A | N/A | $9.66 | -$1.36 |
| 2013 | N/A | N/A | $14.5 | -$6.15 |
| 2012 | N/A | N/A | N/A | -$28.68 |
| 2011 | N/A | N/A | N/A | -$24.9 |
Veracyte PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 29.02 | -42.1% | $32.21 | $1.11 |
| Dec 2025 | 50.12 | -43.06% | $42.1 | $0.84 |
| Sep 2025 | 88.03 | 13.98% | $34.33 | $0.39 |
| Jun 2025 | 77.23 | 12.01% | $27.03 | $0.35 |
| Mar 2025 | 68.95 | -44.28% | $29.65 | $0.43 |
| Dec 2024 | 123.75 | N/A | $39.6 | $0.32 |
| Sep 2024 | N/A | N/A | $34.04 | -$0.13 |
| Jun 2024 | N/A | N/A | $21.67 | -$0.74 |
| Mar 2024 | N/A | N/A | $22.16 | -$0.93 |
| Dec 2023 | N/A | N/A | $27.51 | -$1.02 |
| Sep 2023 | N/A | N/A | $22.33 | -$0.69 |
| Jun 2023 | N/A | N/A | $25.47 | -$0.4 |
| Mar 2023 | N/A | N/A | $22.3 | -$0.41 |
| Dec 2022 | N/A | N/A | $23.73 | -$0.51 |
| Sep 2022 | N/A | N/A | $16.6 | -$0.59 |
VCYT Price vs fair value
VCYT average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
VCYT's current PE ratio is under its 3, 5 and 10-year averages.
PE comparison
Veracyte's price to earnings (P/E) of 42.64 is higher than the Healthcare sector and the industry average. Looking at the Healthcare sector average of 24.29, Veracyte's price to earnings (P/E) is 76% higher.
VCYT PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| VCYT Veracyte Inc | 42.64 | $3.78B |
| MYGN Myriad Genetics Inc | N/A | $408.96M |
| CYTK Cytokinetics Inc | N/A | $8.73B |
Frequently asked questions
What is Veracyte's PE ratio?
VCYT's price to earnings ratio is 42.64 as of Jun 12, 2026.
What is the 3-year average PE ratio for Veracyte (VCYT)?
Over the last 3 years, the average PE ratio for VCYT stock is 72.85.
What is the 5-year average PE ratio for Veracyte (VCYT)?
Over the last 5 years, the average PE ratio for VCYT stock is 72.85.
What is the highest PE ratio for VCYT?
Over the last two years, the Dec 2024 quarter recorded the highest quarterly PE ratio at 123.75.
How does the current PE ratio for VCYT compare to its historical average?
VCYT's current price to earnings ratio is 41% below its 2-year historical average.
How is VCYT's PE ratio calculated (Veracyte PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Jun 12, 2026), Veracyte's share price is $47.33. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $1.11. Therefore, Veracyte's price to earnings ratio for today is 42.64. PE RATIO(42.64) = STOCK PRICE($47.33) / TTM EPS($1.11)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.